Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-18-002112
Filing Date
2018-03-27
Accepted
2018-03-27 09:10:30
Documents
74
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K s109430_10k.htm 10-K 1127569
2 EXHIBIT 23.1 s109430_ex23-1.htm EX-23.1 3450
3 EXHIBIT 31.1 s109430_ex31-1.htm EX-31.1 10084
4 EXHIBIT 31.2 s109430_ex31-2.htm EX-31.2 9977
5 EXHIBIT 32.1 s109430_ex32-1.htm EX-32.1 4834
6 EXHIBIT 32.2 s109430_ex32-2.htm EX-32.2 4722
  Complete submission text file 0001615774-18-002112.txt   5723133

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE bthe-20171231.xml EX-101.INS 966233
8 XBRL SCHEMA FILE bthe-20171231.xsd EX-101.SCH 54003
9 XBRL CALCULATION FILE bthe-20171231_cal.xml EX-101.CAL 66009
10 XBRL DEFINITION FILE bthe-20171231_def.xml EX-101.DEF 262906
11 XBRL LABEL FILE bthe-20171231_lab.xml EX-101.LAB 467418
12 XBRL PRESENTATION FILE bthe-20171231_pre.xml EX-101.PRE 375322
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 18714197
SIC: 2834 Pharmaceutical Preparations